Lisa Walter's Stock Ratings

RBC Capital Analyst

Lisa Walter is an analyst at RBC Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025

Updated: Dec 15, 2025

Overall Average Return

30.4%

Smart Score

75.5%

Overall Average Return Percentile

86th

Number of Ratings

11
Buy NowGet Alert
11/14/2025MGTXBuy Now
MeiraGTx Hldgs
$9.0876.21%$12 → $16MaintainsOutperformGet Alert
11/11/2025FDMTBuy Now
4D Molecular Therapeutics
$10.94192.5%$26 → $32MaintainsOutperformGet Alert
11/06/2025VRDNBuy Now
Viridian Therapeutics
$32.9536.59%$41 → $45MaintainsOutperformGet Alert
11/06/2025EYPTBuy Now
EyePoint Pharmaceuticals
$16.64134.38%$28 → $39MaintainsOutperformGet Alert
10/30/2025UTHRBuy Now
United Therapeutics
$495.0418.58%$569 → $587MaintainsOutperformGet Alert
10/28/2025ADVMBuy Now
Adverum Biotechnologies
$4.60-13.04%$3 → $4MaintainsSector PerformGet Alert
10/21/2025FDMTBuy Now
4D Molecular Therapeutics
$10.94137.66%$26 → $26ReiteratesOutperform → OutperformGet Alert
09/26/2025UTHRBuy Now
United Therapeutics
$495.0414.94% → $569Initiates → OutperformGet Alert
08/07/2025VRDNBuy Now
Viridian Therapeutics
$32.9524.45%$45 → $41MaintainsOutperformGet Alert
08/01/2025APLSBuy Now
Apellis Pharmaceuticals
$24.25-21.65%$17 → $19MaintainsSector PerformGet Alert
06/17/2025EYPTBuy Now
EyePoint Pharmaceuticals
$16.6468.27% → $28Initiates → OutperformGet Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free